Sight Sciences, Inc. SGHT Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Dry Eye | $2.6M-22.4% | $1.64M-58.6% | $1.22M-76.8% | $2.56M-51.9% | $3.35M-46.5% | |
| Surgical Glaucoma | $76.95M+2.9% | $75.72M-0.2% | $74.83M+0.7% | $73.75M-0.4% | $74.76M-0.6% | |
| Gross Profit by Business | ||||||
| Dry Eye | $1.67M-0.9% | $972K-46.9% | $632K-74.9% | $1.29M-52.3% | $1.69M-49.2% | |
| Surgical Glaucoma | $66.88M+2.5% | $65.69M-1.1% | $64.81M-0.6% | $63.86M-2.4% | $65.22M-2.0% | |
| Cost of Goods Sold by Business | ||||||
| Dry Eye | $929K-44.2% | $667K-68.7% | $587K-78.6% | $1.27M-51.5% | $1.66M-43.6% | |
| Surgical Glaucoma | $10.07M+5.6% | $10.03M+6.1% | $10.03M+10.1% | $9.89M+14.2% | $9.54M+9.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Sight Sciences, Inc. break its business down?
- Sight Sciences, Inc. (SGHT) reports revenue by business across 2 parts — Dry Eye and Surgical Glaucoma. Each is extracted from the segment footnotes and tracked over time.
- Where does Sight Sciences, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Sight Sciences, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
